Trial intelligence / Profile preview

Anakinra in Smoldering/Indolent Multiple Myeloma

NCT00635154Phase 2Completed

Sponsor
Mayo Clinic
Start
Dec 2002
Primary completion
Dec 2009
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in smoldering multiple myeloma (SMM), multiple myeloma (MM), sponsored by Mayo Clinic. Started Dec 2002; status: completed.

02

Drugs

anakinra
03

Conditions

smoldering multiple myeloma (SMM)multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00635154.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00635154.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call